Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The concept of immunochemosurgery in gastric cancer.

× No keyword cloud information.

32 in total

1. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors: P LAUREN
Journal: Acta Pathol Microbiol Scand Date: 1965

2. Letter: Effect of BCG on haemopoietic stem cells.

Authors: P Pouillart; T Palangie; L Schwarzenberg; H Brugerie; J Lhéritier; G Mathé
Journal: Biomedicine Date: 1975-12-20

3. Prognosis for carcinoma of the stomach.

Authors: S O Hoerr
Journal: Surg Gynecol Obstet Date: 1973-08

4. Demonstration of antibodies against human malignant melanoma by immunofluorescence.

Authors: D L Morton; R A Malmgren; E C Holmes; A S Ketcham
Journal: Surgery Date: 1968-07 Impact factor: 3.982

5. Postoperative long-term immunochemotherapy for esophageal carcinoma. 5 year survival.

Authors: Y Okudaira; K Sugimachi; K Inokuchi; H Kai; H Kuwano; H Matsuura
Journal: Jpn J Surg Date: 1982

6. Gastric cancer: a controlled trial of adjuvant chemotherapy following gastrectomy.

Authors: J R Blake; J D Hardcastle; R G Wilson
Journal: Clin Oncol Date: 1981-03

Review 7. Immunological factors which influence response to immunotherapy in malignant melanoma.

Authors: D Morton; F R Eilber; R A Malmgren; W C Wood
Journal: Surgery Date: 1970-07 Impact factor: 3.982

8. Preoperative cell-mediated immune status of gastric cancer patients.

Authors: K Orita; H Miwa; H Fukuda; M Yumura; Y Uchida
Journal: Cancer Date: 1976-12 Impact factor: 6.860

9. A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma: The Gastrointestinal Tumor study Group.

Authors:
Journal: Cancer Date: 1982-04-01 Impact factor: 6.860

10. Immunotherapy for acute myelogenous leukaemia.

Authors: R L Powles; D Crowther; C J Bateman; M E Beard; T J McElwain; J Russell; T A Lister; J M Whitehouse; P F Wrigley; M Pike; P Alexander; G H Fairley
Journal: Br J Cancer Date: 1973-11 Impact factor: 7.640

5 in total

1. A comprehensive multi-institutional study on postoperative adjuvant immunotherapy with oral streptococcal preparation OK-432 for patients after gastric cancer surgery. Kyoto Research Group for Digestive Organ Surgery.

Authors:
Journal: Ann Surg Date: 1992-07 Impact factor: 12.969

2. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients.

Authors: J P Kim; Y W Kim; H K Yang; D Y Noh
Journal: World J Surg Date: 1994 Nov-Dec Impact factor: 3.352

3. Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for gastric cancer.

Authors: Y Nio; M Tsubono; K Kawabata; Y Masai; H Hayashi; C Meyer; K Inoue; T Tobe
Journal: Ann Surg Date: 1993-07 Impact factor: 12.969

4. Gastric cancer: a curable disease in Britain.

Authors: H M Sue-Ling; D Johnston; I G Martin; M F Dixon; M R Lansdown; M J McMahon; A T Axon
Journal: BMJ Date: 1993-09-04

5. Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.

Authors: Y Nio; H Nagami; K Tamura; M Tsubono; M Nio; M Sato; K Kawabata; H Hayashi; T Shiraishi; S Imai; T Tsuchitani; J Mizuta; M Nakagawa; M Fukumoto
Journal: Br J Cancer Date: 1999-05 Impact factor: 7.640

5 in total